Countries China

GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity...

 July 07, 2023 | News

TiumBio and Hansoh Pharma Secure NMPA Approval for 'HS-10518/TU2670' Clinical Trial in China

TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...

 July 06, 2023 | News

China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chi...

 July 05, 2023 | News

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...

 July 05, 2023 | News

Merck Invests €70 Million to Expand Reagent Manufacturing in China

Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...

 July 04, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

 July 03, 2023 | News

Chime Biologics, Leads Biolabs, and BeiGene Join Forces to Advance LBL-007 mAb Globally

Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials in China. BeiGe...

 July 03, 2023 | News

Harbour BioMed's Batoclimab Receives NMPA Acceptance for Generalized Myasthenia Gravis Treatment

"Anti-FcRn treatment is at the center of focus in gMG disease area. Batoclimab is the first anti-FcRn treatment completed clinical development with po...

 June 30, 2023 | News

BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification

BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...

 June 30, 2023 | News

Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D

This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...

 June 29, 2023 | News

Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment

Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...

 June 29, 2023 | News

OBiO Technology adds scale-X™ and NevoLine™ Upstream Platform to Accelerate Gene Therapy Manufacturing in Shanghai

  The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...

 June 28, 2023 | News

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...

 June 28, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

  The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

 June 27, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close